Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
841 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Caspase 8 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
CASP8 |
SynonymsGene synonyms aliases
|
ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 |
ChromosomeChromosome number
|
2 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
2q33.1 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs17860424 |
C>T |
Pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs587776665 |
GT>- |
Pathogenic |
Downstream transcript variant, genic downstream transcript variant, frameshift variant, non coding transcript variant, coding sequence variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0001525 |
Process |
Angiogenesis |
ISS |
|
GO:0004197 |
Function |
Cysteine-type endopeptidase activity |
IDA |
16920334, 19240112 |
GO:0004197 |
Function |
Cysteine-type endopeptidase activity |
TAS |
|
GO:0005123 |
Function |
Death receptor binding |
IEA |
|
GO:0005164 |
Function |
Tumor necrosis factor receptor binding |
IEA |
|
GO:0005515 |
Function |
Protein binding |
IPI |
9208847, 9334338, 9343261, 9560245, 10442631, 12198154, 12884866, 12887920, 12888622, 14612908, 15069192, 15509781, 16498403, 16936772, 17047155, 17159907, 17170703, 17245429, 17479112, 18086677, 18245485, 18328427, 18485876, 18846110, 19060883, 19176810, 19427028, 19524512, 1952451 |
GO:0005654 |
Component |
Nucleoplasm |
IDA |
|
GO:0005737 |
Component |
Cytoplasm |
IBA |
21873635 |
GO:0005739 |
Component |
Mitochondrion |
TAS |
10891503 |
GO:0005741 |
Component |
Mitochondrial outer membrane |
TAS |
|
GO:0005829 |
Component |
Cytosol |
IDA |
17167422 |
GO:0005829 |
Component |
Cytosol |
TAS |
|
GO:0005856 |
Component |
Cytoskeleton |
TAS |
10891503 |
GO:0006508 |
Process |
Proteolysis |
IDA |
12888622 |
GO:0006915 |
Process |
Apoptotic process |
IBA |
21873635 |
GO:0006915 |
Process |
Apoptotic process |
IGI |
17599062 |
GO:0006915 |
Process |
Apoptotic process |
IMP |
22891283 |
GO:0006919 |
Process |
Activation of cysteine-type endopeptidase activity involved in apoptotic process |
IBA |
21873635 |
GO:0006919 |
Process |
Activation of cysteine-type endopeptidase activity involved in apoptotic process |
TAS |
|
GO:0007166 |
Process |
Cell surface receptor signaling pathway |
TAS |
|
GO:0007507 |
Process |
Heart development |
ISS |
|
GO:0008233 |
Function |
Peptidase activity |
IDA |
19740745 |
GO:0008233 |
Function |
Peptidase activity |
IMP |
17047155 |
GO:0008234 |
Function |
Cysteine-type peptidase activity |
TAS |
8681376 |
GO:0008625 |
Process |
Extrinsic apoptotic signaling pathway via death domain receptors |
IBA |
21873635 |
GO:0009409 |
Process |
Response to cold |
IEA |
|
GO:0010803 |
Process |
Regulation of tumor necrosis factor-mediated signaling pathway |
TAS |
|
GO:0030101 |
Process |
Natural killer cell activation |
TAS |
18309324 |
GO:0030225 |
Process |
Macrophage differentiation |
IBA |
21873635 |
GO:0030225 |
Process |
Macrophage differentiation |
TAS |
18309324 |
GO:0031264 |
Component |
Death-inducing signaling complex |
IDA |
11101870, 21803845 |
GO:0031265 |
Component |
CD95 death-inducing signaling complex |
IDA |
11717445 |
GO:0031625 |
Function |
Ubiquitin protein ligase binding |
IPI |
15069192 |
GO:0032025 |
Process |
Response to cobalt ion |
IEA |
|
GO:0032355 |
Process |
Response to estradiol |
IEA |
|
GO:0032496 |
Process |
Response to lipopolysaccharide |
IEA |
|
GO:0032731 |
Process |
Positive regulation of interleukin-1 beta production |
IMP |
22267217 |
GO:0032991 |
Component |
Protein-containing complex |
IDA |
22267217 |
GO:0034138 |
Process |
Toll-like receptor 3 signaling pathway |
TAS |
|
GO:0034612 |
Process |
Response to tumor necrosis factor |
IMP |
10521396 |
GO:0035666 |
Process |
TRIF-dependent toll-like receptor signaling pathway |
TAS |
|
GO:0035877 |
Function |
Death effector domain binding |
IBA |
21873635 |
GO:0035877 |
Function |
Death effector domain binding |
IPI |
11717445 |
GO:0036462 |
Process |
TRAIL-activated apoptotic signaling pathway |
IDA |
21785459 |
GO:0039650 |
Process |
Suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process |
TAS |
|
GO:0042110 |
Process |
T cell activation |
TAS |
18309324 |
GO:0042113 |
Process |
B cell activation |
TAS |
18309324 |
GO:0042802 |
Function |
Identical protein binding |
IPI |
16169070, 17170703 |
GO:0043005 |
Component |
Neuron projection |
IEA |
|
GO:0043065 |
Process |
Positive regulation of apoptotic process |
ISS |
|
GO:0043123 |
Process |
Positive regulation of I-kappaB kinase/NF-kappaB signaling |
IEP |
12761501 |
GO:0043123 |
Process |
Positive regulation of I-kappaB kinase/NF-kappaB signaling |
IMP |
12884866 |
GO:0043124 |
Process |
Negative regulation of I-kappaB kinase/NF-kappaB signaling |
IMP |
17047155 |
GO:0044297 |
Component |
Cell body |
IEA |
|
GO:0044877 |
Function |
Protein-containing complex binding |
IEA |
|
GO:0045121 |
Component |
Membrane raft |
IEA |
|
GO:0045471 |
Process |
Response to ethanol |
IEA |
|
GO:0045651 |
Process |
Positive regulation of macrophage differentiation |
IMP |
17047155 |
GO:0045862 |
Process |
Positive regulation of proteolysis |
IDA |
18387192 |
GO:0046677 |
Process |
Response to antibiotic |
IEA |
|
GO:0051603 |
Process |
Proteolysis involved in cellular protein catabolic process |
IMP |
10521396 |
GO:0060544 |
Process |
Regulation of necroptotic process |
TAS |
|
GO:0060546 |
Process |
Negative regulation of necroptotic process |
IDA |
31827280 |
GO:0060546 |
Process |
Negative regulation of necroptotic process |
ISS |
|
GO:0060715 |
Process |
Syncytiotrophoblast cell differentiation involved in labyrinthine layer development |
TAS |
18309324 |
GO:0070269 |
Process |
Pyroptosis |
ISS |
|
GO:0070423 |
Process |
Nucleotide-binding oligomerization domain containing signaling pathway |
TAS |
|
GO:0071260 |
Process |
Cellular response to mechanical stimulus |
IEP |
19593445 |
GO:0071407 |
Process |
Cellular response to organic cyclic compound |
IEA |
|
GO:0071550 |
Process |
Death-inducing signaling complex assembly |
TAS |
|
GO:0097110 |
Function |
Scaffold protein binding |
IPI |
21785459 |
GO:0097153 |
Function |
Cysteine-type endopeptidase activity involved in apoptotic process |
IBA |
21873635 |
GO:0097153 |
Function |
Cysteine-type endopeptidase activity involved in apoptotic process |
IDA |
31827280 |
GO:0097153 |
Function |
Cysteine-type endopeptidase activity involved in apoptotic process |
IMP |
21737330 |
GO:0097190 |
Process |
Apoptotic signaling pathway |
IMP |
11101870 |
GO:0097190 |
Process |
Apoptotic signaling pathway |
TAS |
|
GO:0097191 |
Process |
Extrinsic apoptotic signaling pathway |
IDA |
21785459 |
GO:0097194 |
Process |
Execution phase of apoptosis |
IMP |
21737330 |
GO:0097194 |
Process |
Execution phase of apoptosis |
ISS |
|
GO:0097194 |
Process |
Execution phase of apoptosis |
TAS |
|
GO:0097199 |
Function |
Cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
IBA |
21873635 |
GO:0097199 |
Function |
Cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
IMP |
11717445, 21980415 |
GO:0097200 |
Function |
Cysteine-type endopeptidase activity involved in execution phase of apoptosis |
IBA |
21873635 |
GO:0097202 |
Process |
Activation of cysteine-type endopeptidase activity |
IDA |
18387192 |
GO:0097264 |
Process |
Self proteolysis |
ISS |
|
GO:0097296 |
Process |
Activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
TAS |
|
GO:0097342 |
Component |
Ripoptosome |
IDA |
21737330 |
GO:1900740 |
Process |
Positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway |
TAS |
|
GO:1901216 |
Process |
Positive regulation of neuron death |
IEA |
|
GO:1902041 |
Process |
Regulation of extrinsic apoptotic signaling pathway via death domain receptors |
TAS |
|
GO:1902042 |
Process |
Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
TAS |
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
Q14790 |
Protein name |
Caspase-8 (CASP-8) (EC 3.4.22.61) (Apoptotic cysteine protease) (Apoptotic protease Mch-5) (CAP4) (FADD-homologous ICE/ced-3-like protease) (FADD-like ICE) (FLICE) (ICE-like apoptotic protease 5) (MORT1-associated ced-3 homolog) (MACH) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10] |
Protein function |
Thiol protease that plays a key role in programmed cell death by acting as a molecular switch for apoptosis, necroptosis and pyroptosis, and is required to prevent tissue damage during embryonic development and adulthood (By similarity). Initiator protease that induces extrinsic apoptosis by mediating cleavage and activation of effector caspases responsible for the TNFRSF6/FAS mediated and TNFRSF1A induced cell death (PubMed:23516580, PubMed:8681376, PubMed:8681377, PubMed:9006941, PubMed:9184224, PubMed:8962078). Cleaves and activates effector caspases CASP3, CASP4, CASP6, CASP7, CASP9 and CASP10 (PubMed:8962078, PubMed:9006941). Binding to the adapter molecule FADD recruits it to either receptor TNFRSF6/FAS mediated or TNFRSF1A (PubMed:8681376, PubMed:8681377). The resulting aggregate called death-inducing signaling complex (DISC) performs CASP8 proteolytic activation (PubMed:9184224). The active dimeric enzyme is then liberated from the DISC and free to activate downstream apoptotic proteases (PubMed:9184224). Proteolytic fragments of the N-terminal propeptide (termed CAP3, CAP5 and CAP6) are likely retained in the DISC (PubMed:9184224). In addition to extrinsic apoptosis, also acts as a negative regulator of necroptosis: acts by cleaving RIPK1 at 'Asp-324', which is crucial to inhibit RIPK1 kinase activity, limiting TNF-induced apoptosis, necroptosis and inflammatory response (PubMed:31827280, PubMed:31827281). Also able to initiate pyroptosis by mediating cleavage and activation of gasdermin-D (GSDMD): GSDMD cleavage promoting release of the N-terminal moiety (Gasdermin-D, N-terminal) that binds to membranes and forms pores, triggering pyroptosis (By similarity). Initiates pyroptosis following inactivation of MAP3K7/TAK1 (By similarity). Also acts as a regulator of innate immunity by mediating cleavage and inactivation of N4BP1 downstream of TLR3 or TLR4, thereby promoting cytokine production (By similarity). May participate in the Granzyme B (GZMB) cell death pathways (PubMed:8755496). Cleaves PARP1 (PubMed:8681376). ; [Isoform 5]: Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex. ; [Isoform 6]: Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex. ; [Isoform 7]: Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex (Probable). Acts as an inhibitor of the caspase cascade (PubMed:12010809). ; [Isoform 8]: Lacks the catalytic site and may interfere with the pro-apoptotic activity of the complex. |
PDB |
1F9E
,
1I4E
,
1QDU
,
1QTN
,
2C2Z
,
2FUN
,
2K7Z
,
2Y1L
,
3H11
,
3KJN
,
3KJQ
,
4JJ7
,
4PRZ
,
4PS1
,
4ZBW
,
5H31
,
5H33
,
5JQE
,
5L08
,
6AGW
,
6PX9
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF01335 |
DED |
3 → 84 |
Death effector domain |
Domain |
PF01335 |
DED |
101 → 180 |
Death effector domain |
Domain |
PF00656 |
Peptidase_C14 |
234 → 476 |
|
Domain |
|
Sequence |
|
Sequence length |
479 |
Interactions |
View interactions |
|
|